The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence

By Esteban Cardeñosa Eva   Bolufer Gilabert Pascual   Juan Jiménez Inmaculada   Palanca Suela Sarai   Barragán González Eva   González Anguix Virginia   Lerma Alejos Enrique   Chirivella González Isabel   Segura Huerta Ángel   Guillén Ponce Carmen   Martínez de Dueñas Eduardo   Cuevas Cuerda Dolores   Salas Trejo Dolores  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 291-295

Springer Publishing Company

Access to resources Recommend Favorite

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

By Neibergs Holly  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations

By Steffensen Ane   Jønson Lars   Ejlertsen Bent   Gerdes Anne-Marie   Nielsen Finn   Hansen Thomas  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 283-287

Springer Publishing Company

Access to resources Recommend Favorite